secwatch.observer — SEC 8-K summary
======================================

Issuer:     Advanced Biomed Inc. (ADVB)
CIK:        0001941029
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001213900-26-020807
Event type: other
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Advanced Biomed announces 1-for-20 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse split effective Feb 20, 2026; every 20 shares become 1 share, par value unchanged $0.001.
- Outstanding shares reduced from 27,290,710 to approx 1,364,536; authorized shares unchanged.
- New CUSIP 00752P203; stock continues trading under symbol ADVB; no fractional shares issued.
- Split aims to meet Nasdaq minimum bid price of $1.00 per share.
- Stockholder approval obtained via written consent on Jan 12, 2026; board set ratio Jan 30.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1941029/000121390026020807/0001213900-26-020807-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1941029/000121390026020807/ea0278448-8k_advanced.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-020807

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer